Engergy Sector in Review; Exxon inks Deal with Montan While Estimates Posts...
Montana executives have confirmed a $1.6 million settlement with Exxon Mobil Corporation (NYSE:XOM) over an oil pipeline break to facilitate spilled 1,500 barrels of crude into the scenic Yellowstone...
View ArticleAntares Pharma (NASDAQ:ATRS) Plans to Raise $47 Million from 12.5 Million...
Antares Pharma Inc. (NASDAQ:ATRS), makers of self-injectable drugs, reported on Wednesday that it aims to vend 12.5 million shares of its stock for $4 a share, raising around $47 million after costs....
View ArticleCovidien PLC (NYSE:COV) Superior Sales Masked by Split Off Costs, Outlook...
Covidien PLC (NYSE:COV) witnessed a 0.2% drop in fiscal first-quarter earnings as costs to divide the health-care products firm weighed over its bubbly sales. The firm also lifted its fiscal 2013 sales...
View ArticleCovidien (NYSE:COV) Fiscal First Quarter Earnings Tumbles but Beats Wall...
Covidien plc (NYSE:COV) reported on Friday that fiscal Q1 earnings plunged as a boost in outlays and higher tax from medical gadget sales, however quarterly results of the Irish company still able to...
View ArticleCorning (NYSE:GLW) Fiscal Fourth Quarter Net Tumbles on Higher Charges – GLW,...
Corning Incorporated (NYSE:GLW) reported that fiscal Q4 earnings moved down 42% as the company booked higher charges linked to revamping, impairment and special items, which masked a boost in revenue....
View ArticleICU Medical (NASDAQ:ICUI) Declares Fiscal Q4 Profit Plunges 31% – ICUI, MMSI,...
ICU Medical, Incorporated (NASDAQ:ICUI) announced on Monday that fiscal Q4 earnings moved down 31 percent as the company’s previous year results were lifted by a special gain of asset-sale. The...
View ArticleHealthcare Sector Recap: HCA Holdings (HCA) and Becton, Dickinson (BDX) Post...
Healthcare sector finished higher on Tuesday with +0.81% change. If we look at the best movers of the sector so Neurocrine Biosciences, Inc (NASDAQ:NBIX) and Keryx Biopharmaceuticals (NASDAQ:KERX) were...
View ArticleCovidien (NYSE:COV) Post 12% Drop in Fiscal First Quarter Profit – COV, TFX,...
Covidien plc (NYSE:COV), a producer of operating-room gear, generic drugs and other medical supplies, announced fiscal Q2 earnings tumble 12 percent as overhauling outlays and other items masked the...
View Article
